EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Biobanks: can they overcome controversy and deliver on their promise to unravel the origins of common diseases?


Medical Education 40(6): 500-502
Biobanks: can they overcome controversy and deliver on their promise to unravel the origins of common diseases?


Accession: 048378911

PMID: 16700763

DOI: 10.1111/j.1365-2929.2006.02494.x



Related references

Biobanks between common good and private interest: the example of umbilical cord blood private biobanks. Recent Patents on Dna & Gene Sequences 5(3): 166-168, 2012

The ethics of expectations: biobanks and the promise of personalised medicine. Monash Bioethics Review 28(1): 5.1-512, 2009

Realizing the promise of population biobanks: a new model for translation. Human Genetics 130(3): 333-345, 2011

Will investments in large-scale prospective cohorts and biobanks limit our ability to discover weaker, less common genetic and environmental contributors to complex diseases?. Environmental Health Perspectives 113(2): 119-122, 2005

An analysis of the debate on the concept of death as an instrument to unravel controversy. Lakartidningen 87(7): 462-462, 1990

Progress and promise in understanding the genetic basis of common diseases. Proceedings. Biological Sciences 282(1821): 20151684-20151684, 2015

Who will deliver on the promise?. American Journal of Public Health 102(1): 17-21, 2012

Deliver on a promise. Scientific American 311(1): S12-S13, 2014

Statoil; we deliver what we promise. Annual Meeting Expanded Abstracts - American Association of Petroleum Geologists 13(Pages 91, 2004

Medicines for pediatric oncology: can we overcome the failure to deliver?. Expert Review of Clinical Pharmacology 5(5): 493-495, 2013